Pr Christophe Massard

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

• Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy. (25 juil. 2025)
• [Proposals to develop innovation and research in cancer and optimize care for patients affected by cancer]. (9 juil. 2025)
• The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. (8 juil. 2025)
• First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors. (1 juil. 2025)
• Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. (7 juin 2025)